We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 26, 2021

Fixed Dose Combination of Capecitabine and Cyclophosphamide in Metastatic Breast Cancer

The Breast


Additional Info

The Breast
Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter study
Breast 2021 Dec 01;60(xx)147-154, S Gupta, G Biswas, S Babu, TM Maksud, KC Lakshmaiah, JG Patel, G Raja, RR Boya, P Patil, K Choudhury, SA Bondarde, RS Neve, G Bhat, G Mamillapalli, AA Patel, P Patel, N Joshi, V Bajaj, MA Khan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading